Patient-reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis.

Reinhard StauderJérémy LambertSandra Desruol-AllardinIsabelle SavreLona GauglerIgor StojkovUwe SiebertHélène Chevrou-Séverac

Published in: European journal of haematology (2020)

This research indicated an underuse of AML/MDS-specific PROMs for these two indications in clinical studies and labeling claims. However, AML/MDS-specific instruments in development might be considered in future studies.

Keyphrases

patient reported outcomes
acute myeloid leukemia
allogeneic hematopoietic stem cell transplantation
case control
health insurance
single cell
current status
acute lymphoblastic leukemia